In earlier studies with three GWAS of ER-negative breast cancer patients, including the TNBC group [85,86], it has been observed that rs4245739 in the 3′UTR region of MDM4, creating a novel site for miR-191 [87], is specific to triple negative breast cancer patients [16]. Here, MDM4 is linked to triple-negative breast carcinoma.